ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Headache,Headaches NEC,Headaches,Nerv,N
2,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
4,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
6,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
7,1,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8,1,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,2,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
10,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
10,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
11,1,Dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
11,3,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
11,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
11,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
13,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
14,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
14,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
14,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
14,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
15,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
16,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
16,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
17,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
18,1,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
19,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
20,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
20,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
20,3,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
20,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
21,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
21,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
22,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
22,2,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
22,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,4,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
22,5,Noninfective conjunctivitis,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
22,6,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
22,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
23,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
24,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Allodynia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
26,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
27,1,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
28,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
28,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
28,3,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
28,4,Soliloquy,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
29,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
29,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
29,3,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
29,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
30,1,Nonspecific reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
31,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
32,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
32,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
32,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
33,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
33,2,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
33,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
34,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
34,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
34,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
35,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
38,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
38,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
38,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
39,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
40,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
42,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
44,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
46,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
